Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00364) | |||||
---|---|---|---|---|---|
Name |
Levorphanol
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
levorphanol; Levorphan; Aromarone; Methorphinan; Racemethorphanum; Levo-Dromoran; Methorfinan [Czech]; Levorfanolo [DCIT]; Racemorphan; 17-Methylmorphinan-3-ol; Levorfanol [INN-Spanish]; Levorphanolum [INN-Latin]; Racemorfano [INN-Spanish]; Levorphanal; Ro 1-5431; DEA No. 9220; DEA No. 9733; L-morphan; (-)-3-Hydroxy-N-methylmorphinan; UNII-27618J1N2X; Morphinan-3-ol, 17-methyl-; Morphinan, 3-hydroxy-17-methyl-; Cetarin; Dromoran; CHEMBL592; Racemic dromoran; (-)-N-Methylmorphinan-3-ol; CHEBI:6444; LEVORPHANOL HYDROCHLORIDE; 77-07-6 (free); Orphan; 27618J1N2X; 297-90-5; Levorfanolo; Levorphanolum; Methorfinan; Racemorfano; Racemorphane; Racemorphanum; Levorfanol; N-Methyl-3-hydroxymorphinan; Racemorphan [INN:BAN]; 1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, l-; 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, l-; Racemorphane [INN-French]; Racemorphanum [INN-Latin]; Dextro-Dromoran; dl-3-Hydroxy-N-methylmorphinan; (+-)-17-Methylmorphinan-3-ol; (4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-ol; 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-; Levorphanol dl-form; Levorphanol (INN); NU 2206; HSDB 3349; (+-)-3-Hydroxy-N-methylmorphinan; Levorphanol [INN:BAN]; (+)-N-Methylmorphinan-3-ol; EINECS 201-002-6; EINECS 206-048-0; (+-)-N-Methylmorphinan-3-ol; Morphinan, 3-hydroxy-N-methyl, (+)-; 1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, dl-mixture; d-Form of levorphanol; Morphinan-3-ol, 17-methyl-, (-)-; LEVORPHANOL-tartarate; Morphinan-3-ol, 17-methyl-, (+-)-; Morphinan, 3-hydroxy-N-methyl-, (+-)-; 2H-10, 4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, dl-; SCHEMBL24335; GTPL7595; IDS-NL-007; DTXSID3023213; BDBM82427; (+)-cis-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol; (-) 3-hydroxy-N-methylmorphinan; 2H-10,4a-(Iminoethano)phenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, (+)-; BDBM224028; DTXSID301016136; ZINC3812984; BDBM50017233; BDBM50369518; 17-Methylmorphinan-3-ol, (+)- #; DB00854; CAS_5985-38-6; C08014; D08123; Q2579108; UNII-V7R79HN3XD component JAQUASYNZVUNQP-USXIJHARSA-N; 9.alpha.,13.alpha.,14.alpha.-Morphinan-3-ol, 17-methyl-; Morphinan-3-ol, 17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-; (1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Cerebral stroke | ICD-11: 8B11 | [1] | ||
PubChem CID | |||||
Formula |
C17H23NO
|
||||
Canonical SMILES |
CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O
|
||||
InChI |
1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1
|
||||
InChIKey |
JAQUASYNZVUNQP-USXIJHARSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5359272"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 257.37 | Topological Polar Surface Area | 23.5 | |
XlogP | 3.1 | Complexity | 357 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Levorphanol 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose; Talc; Corn starch
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Valeant Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Roxane Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.